Join the Non-Small Cell Lung Cancer group to help and get support from people like you.
Non-Small Cell Lung Cancer News (Page 2)
Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC
New Guidelines Upped Lung Cancer Screenings, But Gaps Remain
MONDAY, March 24, 2025 – More smokers are getting CT screenings for lung cancer, thanks to guideline changes that included younger people and those who’ve smoked less, a new study says. However, s...
Lung Cancer Screening Adherence Rates Decline Annually After Baseline Screening
THURSDAY, March 20, 2025 – Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individuals undergoing lung cancer screening (LCS); however,...
Length of Stay After Lung Cancer Surgery Longer With Wildfire in County of Treating Facility
FRIDAY, March 14, 2025 – Patients with non-small cell lung cancer undergoing lobectomy or pneumonectomy whose treatment facility was in a U.S. county impacted by a wildfire disaster during recovery...
What Cancer Screenings Do You Need? A Quick Guide
SATURDAY, Feb. 15, 2025 – Cancer screenings can save lives by detecting cancer early, when treatment is most effective. With an estimated 2 million new cancer cases expected in 2025, regular...
Survival Improved With Lobectomy, Segmentectomy in Early NSCLC
TUESDAY, Jan. 28, 2025 – For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are associated with improved long-term survival...
Integrated Care Boosts Smoking Cessation When Undergoing Lung Cancer Screening
FRIDAY, Jan. 17, 2025 – Integrated care (IC) involving medication and intensive counseling provides the best opportunity for smoking cessation in the context of lung cancer screening (LCS),...
AI Can Guide Acquisition of Diagnostic-Quality Lung Ultrasound Images
FRIDAY, Jan. 17, 2025 – Trained health care professionals (THCPs), including medical assistants, respiratory therapists, and nurses, with artificial intelligence (AI) assistance can achieve lung...
Shifts in Trends Noted for Trachea, Bronchus, Lung Cancer Mortality
WEDNESDAY, Jan. 15, 2025 – Tobacco-associated trachea, bronchus, and lung (TBL) cancer mortality is declining, while ambient particulate matter (PM)-associated TBL cancer mortality is increasing,...
Rurality Partly Explains Racial Difference in Distance to Lung Cancer Screening
MONDAY, Jan. 13, 2025 – Differences in distance to lung cancer screening (LCS) facilities by race and ethnicity are partly explained by rurality, according to a study published online Jan. 14 in the...
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
FRIDAY, Jan. 3, 2025 – The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid...
FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications
PRINCETON, N.J.--(BUSINESS WIRE) December 27, 2024 – Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) granted approval for Opdivo Qvantig (nivolumab...
FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or...
Are Microplastics In the Air Putting Your Fertility At Risk?
WEDNESDAY, Dec. 18, 2024 – Microscopic plastic particles in the air could be contributing to a wide variety of health problems, including lung and colon cancers. Tires and degrading garbage shed...
Metformin Beneficial in Lung Cancer Patients With Overweight, Obesity
TUESDAY, Dec. 10, 2024 – In non-small cell lung cancer (NSCLC) patients with overweight or obesity, metformin may improve lung cancer-specific clinical outcomes, according to a study published...
FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) – Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage oncology company developing innovative,...